Patents Assigned to Theranos IP Company, LLC
-
Patent number: 10670588Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.Type: GrantFiled: July 22, 2016Date of Patent: June 2, 2020Assignee: Theranos IP Company, LLCInventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
-
Patent number: 10634667Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.Type: GrantFiled: September 8, 2015Date of Patent: April 28, 2020Assignee: Theranos IP Company, LLCInventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
-
Patent number: 10627418Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: GrantFiled: May 23, 2016Date of Patent: April 21, 2020Assignee: Theranos IP Company, LLCInventors: James Wasson, Pey-Jiun Ko, Joy Roy, Elizabeth A. Holmes
-
Patent number: 10620193Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.Type: GrantFiled: April 12, 2018Date of Patent: April 14, 2020Assignee: Theranos IP Company, LLCInventors: Ian Gibbons, Michael O'Connell
-
Patent number: 10620192Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.Type: GrantFiled: July 22, 2016Date of Patent: April 14, 2020Assignee: Theranos IP Company, LLCInventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
-
Patent number: 10613080Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.Type: GrantFiled: September 8, 2015Date of Patent: April 7, 2020Assignee: Theranos IP Company, LLCInventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
-
Publication number: 20200096527Abstract: Systems and methods are provided for processing a biological sample. In one embodiment, the method comprises receiving a sample vessel containing the sample; retrieving information from an information storage unit associated with the sample; using said information for selecting at least one cartridge front at least two or more different cartridges, each configured for use with a sample processing device; loading at least one or more reagents onto the cartridge, wherein the one or more reagents to be added are selected based at least in part on the information or instructions derived from the information; and placing the sample vessel in the cartridge.Type: ApplicationFiled: August 29, 2019Publication date: March 26, 2020Applicant: Theranos IP Company, LLCInventors: Elizabeth A. Holmes, Adrit Lath
-
Patent number: 10598654Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.Type: GrantFiled: July 22, 2016Date of Patent: March 24, 2020Assignee: Theranos IP Company, LLCInventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
-
Patent number: 10591409Abstract: The devices, systems, and methods disclosed herein provide sample verification capabilities in a single device or system. Devices are disclosed herein. Systems including these devices are also provided. These devices and systems may be configured for verifying sample integrity prior to a subject leaving a sample collection site so that any further samples or other corrective action can occur without having to make a separate visit.Type: GrantFiled: August 29, 2016Date of Patent: March 17, 2020Assignee: Theranos IP Company, LLCInventors: Zachary Morrison, Daniel Young, Sunny Balwani, Michael Chen
-
Patent number: 10565705Abstract: Systems and methods are provided for collecting, preparing, and/or analyzing a biological sample. A sample collection site may be utilized with one or more sample processing device. The sample processing device may be configured to accept a sample from a subject. The sample processing device may perform one or more sample preparation step and/or chemical reaction involving the sample. Data related to the sample may be sent from the device to a laboratory. The laboratory may be a certified laboratory that may generate a report that is transmitted to a health care professional. The health care professional may rely on the report for diagnosing, treating, and/or preventing a disease in the subject.Type: GrantFiled: September 29, 2017Date of Patent: February 18, 2020Assignee: Theranos IP Company, LLCInventor: Elizabeth A. Holmes
-
Patent number: 10557786Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: GrantFiled: May 19, 2016Date of Patent: February 11, 2020Assignee: Theranos IP Company, LLCInventors: Ian Gibbons, Anthony J. Nugent, Anthony Delacruz, Daniel Young, Elizabeth A. Holmes, Andrew Drake, Timothy Michael Kemp, Sunny Balwani, Chinmay Pangarkar
-
Patent number: 10557863Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: GrantFiled: July 1, 2015Date of Patent: February 11, 2020Assignee: Theranos IP Company, LLCInventors: Elizabeth A. Holmes, Michael Chen, John K. Frankovich, Samartha Anekal, Adrit Lath, Alexander Loo, Chinmay Pangarkar, Joy Roy, Timothy Smith, Daniel Young
-
Patent number: 10541896Abstract: Methods and systems are provided for connecting an electronic device to a network. In some situations, the electronic device connects to a first network provider and pings a first server having a static internet protocol address and a second server having a dedicated uniform resource locator. If the electronic device receives a response from the first and second server, the electronic device maintains its connection to the first network provider. Otherwise, the electronic device connects to a second network provider and pings the first and second servers.Type: GrantFiled: February 10, 2017Date of Patent: January 21, 2020Assignee: Theranos IP Company, LLCInventor: Sunny Balwani
-
Patent number: 10537894Abstract: In one embodiment described herein, a cartridge is provided comprising a cartridge frame; a plurality of diluents each in an expandable container; a plurality of reagents each in an expandable container; and a plurality of mixing vessels comprising empty expandable containers.Type: GrantFiled: March 10, 2017Date of Patent: January 21, 2020Assignee: Theranos IP Company, LLCInventors: Gary Frenzel, Samartha Anekal, Daniel Young
-
Patent number: 10534009Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: GrantFiled: September 21, 2015Date of Patent: January 14, 2020Assignee: Theranos IP Company, LLCInventors: Elizabeth A. Holmes, Chinmay Pangarkar, Samartha Anekal
-
Patent number: 10533994Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.Type: GrantFiled: September 28, 2015Date of Patent: January 14, 2020Assignee: Theranos IP Company, LLCInventors: Elizabeth A. Holmes, Shaunak Roy, Ian Gibbons, Shize Daniel Qi, Edmond Ku, Chris Todd, Melissa Takahashi, Bruce Johnson, Jeff Fenton, Keith Moravick, Uwe Springborn, Anthony Delacruz
-
Patent number: 10527554Abstract: This invention is in the field of medical devices. Specifically, the present invention provides fluidic systems having a plurality of reaction sites surrounded by optical barriers to reduce the amount of optical cross-talk between signals detected from various reaction sites. The invention also provides a method of manufacturing fluidic systems and methods of using the systems.Type: GrantFiled: August 29, 2017Date of Patent: January 7, 2020Assignee: Theranos IP Company, LLCInventors: Timothy Michael Kemp, Chris Todd, Ron Oral, Shulin Zeng, John Howard, Jeff Fenton, Elizabeth A. Holmes, Ian Gibbons, Shaunak Roy
-
Patent number: 10522245Abstract: Systems, methods, and devices for detecting infections in a clinical sample are provided. Small-volume clinical samples obtained at a point-of-service (POS) location and may be tested at the POS location for multiple markers for multiple diseases, including upper and lower respiratory diseases. Samples may be tested for cytokines, or for inflammation indicators. Dilution of samples, or levels of detection, may be determined by the condition or past history of a subject. Test results may be obtained within a short amount of time after sample placement in a testing device, or within a short amount of time after being obtained from the subject. A prescription for treatment of a detected disorder may be provided, and may be filled, at the POS location. A bill may be automatically generated for the testing, or for the prescription, may be automatically sent to an insurance provider, and payment may be automatically obtained.Type: GrantFiled: November 21, 2016Date of Patent: December 31, 2019Assignee: Theranos IP Company, LLCInventors: Clarissa Lui, Elizabeth A. Holmes
-
Patent number: 10518265Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: GrantFiled: February 10, 2017Date of Patent: December 31, 2019Assignee: Theranos IP Company, LLCInventors: Elizabeth A. Holmes, Joy Roy, John Kent Frankovich
-
Patent number: 10488643Abstract: The devices, systems, and methods disclosed herein provide sample verification capabilities in a single device or system. Devices are disclosed herein. Systems including these devices are also provided. These devices and systems may be configured for verifying sample integrity prior to a subject leaving a sample collection site so that any further samples or other corrective action can occur without having to make a separate visit.Type: GrantFiled: August 19, 2016Date of Patent: November 26, 2019Assignee: Theranos IP Company, LLCInventors: Zachary Morrison, Daniel Young, Sunny Balwani